|
|
Volumn 27, Issue 1, 2009, Pages 11-12
|
|
JAMA study casts cloud over biologic safety
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MONOCLONAL ANTIBODY;
RECOMBINANT ERYTHROPOIETIN;
BIOMEDICINE;
BIOTECHNOLOGY;
DIALYSIS;
DRUG INDUSTRY;
DRUG MARKETING;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE PERSONNEL;
MULTIPLE SCLEROSIS;
NOTE;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
SAFETY;
ANTIBODIES, MONOCLONAL;
BIOLOGICAL PRODUCTS;
BIOTECHNOLOGY;
CLINICAL TRIALS AS TOPIC;
DRUG INDUSTRY;
EUROPE;
HUMANS;
MALE;
RESEARCH DESIGN;
SAFETY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 60149105523
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0109-11 Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|
